UBS Boosts Bristol-Myers Squibb (BMY) Price Target as Milvexian Data Looms

Bristol-Myers Squibb Company (NYSE:BMY) is included among the 14 Stocks connected the Verge of Becoming Dividend Aristocrats.

On March 6, UBS raised its terms proposal connected Bristol-Myers Squibb Company (NYSE:BMY) to $70 from $65 and maintained a Buy standing connected the shares. The expert said Phase III information for milvexian successful changeable prevention and atrial fibrillation, expected successful the 2nd fractional of the year, represents 1 of the company’s cardinal catalysts successful 2026, according to a probe note.

On March 9, Reuters reported that the institution said its experimental cause for a uncommon signifier of humor crab improved endurance successful a late-stage trial, gathering the study’s main goal. The oral cause mezigdomide, utilized successful operation with carfilzomib and dexamethasone, showed a important betterment successful patients with relapsed aggregate myeloma without the illness worsening. The results were compared with those of patients treated with carfilzomib and dexamethasone alone.

Mezigdomide belongs to a caller people of drugs known arsenic CELMoD. These drugs people the cereblon macromolecule and assistance the assemblage wide myeloma cells much rapidly and efficaciously than older treatments. The institution said the information findings were accordant with the known illustration of mezigdomide and the operation regimen. Patients volition proceed to beryllium monitored for endurance and safety.

Bristol-Myers Squibb Company (NYSE:BMY) is a planetary biopharmaceutical steadfast focused connected discovering, developing, and delivering medicines for superior diseases. Its probe and improvement enactment spans respective areas, including oncology, hematology, immunology, cardiovascular disease, and neuroscience.

While we admit the imaginable of BMY arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 40 Most Popular Stocks Among Hedge Funds Heading into 2026 and 13 Best REIT Dividend Stocks to Invest in

Disclosure: None. Follow Insider Monkey connected Google News.